Authors:
Vaessen, LMB
van Miert, PPMC
van der Mast, BJ
Doumaid, K
Balk, AHMM
Boog, CJP
Weimar, W
Citation: Lmb. Vaessen et al., Immunologic monitoring of the beneficial effect of one HLA-DR-shared bloodtransfusion in heart transplant patients, J HEART LUN, 19(11), 2000, pp. 1098-1107
Authors:
Oei, FBS
Welters, MJP
Knoop, CJ
Vaessen, LMB
Stegmann, APA
Weimar, W
Bogers, AJJC
Citation: Fbs. Oei et al., Circulating donor-specific cytotoxic T lymphocytes with high avidity for donor human leukocyte antigens in pediatric and adult cardiac allograft valved conduit recipients, EUR J CAR-T, 18(4), 2000, pp. 466-472
Authors:
Oei, FBS
Welters, MJP
Vaessen, LMB
Stegmann, APA
Bogers, C
Weimar, W
Citation: Fbs. Oei et al., Induction of cytotoxic T lymphocytes with destructive potential after cardiac valve homograft implantation, J HEART V D, 9(6), 2000, pp. 761-768
Authors:
Koelman, CA
Vaessen, LMB
Balk, AHMM
Weimar, W
Doxiadis, IIN
Claas, FHJ
Citation: Ca. Koelman et al., Donor-derived soluble HLA plasma levels can not be used to monitor graft rejection in heart transplant recipients, TRANSPL IMM, 8(1), 2000, pp. 57-64
Authors:
van der Mast, BJ
van Besouw, NM
de Kuiper, P
Vaessen, LMB
IJzermans, JNM
van Gelder, T
Weimar, W
Citation: Bj. Van Der Mast et al., A longitudinal study of TGF-beta(1) protein levels in renal allograft recipients converted from CsA to MMF or AZA, CLIN TRANSP, 14(1), 2000, pp. 66-69
Authors:
van Riemsdijk-van Overbeeke, IC
Baan, CC
Hesse, CJ
Loonen, EHM
Niesters, HGM
Zietse, R
Weimar, W
Citation: Ic. Van Riemsdijk-van Overbeeke et al., TNF-alpha: mRNA, plasma protein levels and soluble receptors in patients on chronic hemodialysis, on CAPD and with end-stage renal failure, CLIN NEPHR, 53(2), 2000, pp. 115-123
Citation: Pjhs. Gregoor et al., Mycophenolate mofetil, Cellcept (R), a new immunosuppressive drug with great potential in internal medicine, NETH J MED, 57(6), 2000, pp. 233-246
Authors:
Van Riemsdijk, IC
Mulder, PG
De Fijter, JW
Bruijn, JA
Van Hooff, JP
Hoitsma, AJ
Tegzess, AM
Weimar, W
Citation: Ic. Van Riemsdijk et al., Addition of isradipine (Lomir) results in a better renal function after kidney transplantation: A double-blind, randomized, placebo-controlled, multicenter study, TRANSPLANT, 70(1), 2000, pp. 122-126
Authors:
van Besouw, NM
van der Mast, BJ
de Kuiper, P
Gregoor, PJHS
Vaessen, LMB
Ijzermans, JNM
van Gelder, T
Weimar, W
Citation: Nm. Van Besouw et al., Donor-specific T-cell reactivity identifies kidney transplant patients in whom immunosuppressive therapy can be safely reduced, TRANSPLANT, 70(1), 2000, pp. 136-143
Authors:
Gregoor, PJHS
van Gelder, T
van Besouw, NM
van der Mast, BJ
Ijzermans, JNM
Weimar, W
Citation: Pjhs. Gregoor et al., Randomized study on the conversion of treatment with cyclosporine to azathioprine or mycophenolate mofetil followed by dose reduction, TRANSPLANT, 70(1), 2000, pp. 143-148
Authors:
Baan, CC
van Gelder, T
Balk, AHMM
Knoop, CJ
Holweg, CTJ
Maat, LPWM
Weimar, W
Citation: Cc. Baan et al., Functional responses of T cells blocked by anti-CD25 antibody therapy during cardiac rejection, TRANSPLANT, 69(3), 2000, pp. 331-336
Authors:
van den Dorpel, MA
Man in't Veld, AJ
Levi, M
ten Cate, JW
Weimar, W
Citation: Ma. Van Den Dorpel et al., Beneficial effects of conversion from cyclosporine to azathioprine on fibrinolysis in renal transplant recipients, ART THROM V, 19(6), 1999, pp. 1555-1558
Authors:
de Groot-Kruseman, HA
Baan, CC
Mol, WM
Niesters, HGM
Maat, APWM
Balk, AHMM
Weimar, W
Citation: Ha. De Groot-kruseman et al., Intragraft platelet-derived growth factor-alpha and transforming growth factor-beta 1 during the development of accelerated graft vascular disease after clinical heart transplantation, TRANSPL IMM, 7(4), 1999, pp. 201-205
Authors:
de Jong, JJ
van Gelder, T
Ijzermans, JNM
Endtz, HP
Weimar, W
Citation: Jj. De Jong et al., Atypical Mycobacterium infection with dermatological manifestation in a renal transplant recipient, TRANSPLAN I, 12(1), 1999, pp. 71-73
Authors:
Gregoor, PJHS
van Gelder, T
Hesse, CJ
van der Mast, BJ
van Besouw, NM
Weimar, W
Citation: Pjhs. Gregoor et al., Mycophenolic acid plasma concentrations in kidney allograft recipients with or without cyclosporin: a cross-sectional study, NEPH DIAL T, 14(3), 1999, pp. 706-708
Authors:
van Besouw, NM
van der Mast, BJ
Gregoor, PJHS
Hesse, CJ
IJzermans, JNM
van Gelder, T
Weimar, W
Citation: Nm. Van Besouw et al., Effect of mycophenolate mofetil on erythropoiesis in stable renal transplant patients is correlated with mycophenolic acid trough levels, NEPH DIAL T, 14(11), 1999, pp. 2710-2713
Authors:
Kroes, ACM
van Bommel, EFH
Kluytmans, JAW
Weimar, W
Citation: Acm. Kroes et al., Hepatitis B and hemodialysis: The impact of universal precautions in preventing the transmission of bloodborne viruses - Reply, INFECT CONT, 20(3), 1999, pp. 156-157
Authors:
van Riemsdijk-van Overbeeke, IC
Baan, CC
Niesters, HGM
Hesse, CJ
Loonen, EHM
Balk, AHMM
Maat, APWM
Weimar, W
Citation: Ic. Van Riemsdijk-van Overbeeke et al., The TNF-alpha system in heart failure and after heart transplantation - Plasma protein levels, mRNA expression, soluble receptors and plasma buffer capacity, EUR HEART J, 20(11), 1999, pp. 833-840
Authors:
de Groot-Kruseman, HA
Baan, CC
Mol, WM
Niesters, HGM
Maat, APWM
Balk, AHMM
Weimar, W
Citation: Ha. De Groot-kruseman et al., Upregulated transforming growth factor-beta(1) mRNA expression in endomyocardial biopsies during the development of graft vascular disease after clinical heart transplantation, TRANSPLAN P, 31(7), 1999, pp. 2724-2725